Nearly 200 R&D labs stung by anthrax debacle
This article was originally published in Scrip
US government officials stunned lawmakers on 28 July by acknowledging the number of private, academic and federal laboratories that may have received live anthrax from a US military base lab in Utah had doubled from what was reported just last week – growing from 86 to 192, many of them private-sector labs.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.